Verrutop Wart and Verruca Treatment

Verrutop Wart and Verruca Treatment

45.00 ex VAT

Verrutop is a new type of wart treatment. Unlike Cryotherapy or other chemical treatments, Verrutop does not act by freezing or burning the tissue. Instead it denatures the viral protein and desiccates the wart tissue, which then falls off the skin, leaving intact skin underneath.
Treatment is normally quick and painless.

PACK CONTAINS: 4x ampoules 100μll Nitrizinc Complex®, 6 capillaries and an instruction booklet.

Verrutop is a topical solution based on Nitrizinc Complex® for treating skin, palmoplantar and periungual warts and condylomata.

When Verrutop® is applied to a wart, a chemical reaction takes place, which causes mummification of the tissue (dehydration and cellular destruction) and the wart changes colour (white/grey/yellowish). Over time, mummification leads to the spontaneous detachment of a wart.

  • Before using Verrutop®, carefully read the instructions for use.
  • A diagnosis must be made by a doctor/ health professional.
  • Use a new capillary tube in each application to avoid possible contamination of the product.
  • Improper use of the product could cause severe adverse effects.
  • In case of accidental contact with healthy skin or mucous membranes, rinse with plenty of water.
  • Avoid contact with the eyes; in case of accidental contact flush with plenty of water. Because it is a corrosive agent, seek the advice of an eye specialist.
  • In the event of an adverse reaction or hypersensitivity to any of the ingredients, stop treatment and seek the advice of a health professional.
  • The product must always be applied by an adult.
  • Do not ingest. Do not inject.
  • Keep out of sight and reach of children.


  • On healthy skin, on the face, on inflamed skin or mucous membranes, on malignant cutaneous tumours, on flat warts, on ephelides (freckles) or on keloids (intense scarring reaction).
  • On children under the age of 6 years.
  • On women who are pregnant or breast feeding.
  • On patients with arteriopathy and/or peripheral neuropathies, such as diabetics.
  • In case of a concomitant cutaneous pathology, a doctor will decide on the risk/benefit of treatment.
  • In concomitant treatment with other topical wart removers.



  • It should be stored at ambient temperature. Crystallisation may be seen at below 8°C, which does not mean degradation of the product. In this case, wait for the product to return to ambient temperature before using it.
  • Once an ampoule has been opened, Verrutop® must be used within the following 24 hours.
  • After use, the remainder of an ampoule must be emptied under a faucet with running water before being deposited in the appropriate container, together with the capillary tubes.
  • Take unused ampoules in their original packaging to a recycling point at a pharmacy. In case of doubt, ask your pharmacist. This is how you can help protect the environment.